Effects of Exosomes Derived from Kidney Tubular Cells on Diabetic Nephropathy in Rats

Objective One of the severe complications and well-known sources of end stage renal disease (ESRD) from diabetes mellitus is diabetic nephropathy (DN). Exosomes secreted from diverse cells are one of the novel encouraging therapies for chronic renal injuries. In this study, we assess whether extracted exosomes from kidney tubular cells (KTCs) could prevent early stage DN in vivo. Materials and Methods In this experimental, exosomes from conditioned medium of rabbit KTCs (RK13) were purified by ultracentrifuge procedures. The exosomes were assessed in terms of morphology and size, and particular biomarkers were evaluated by transmission electron microscopy (TEM), scanning electron microscopy (SEM), Western blot, atomic force microscopy (AFM) and Zetasizer Nano analysis. The rats were divided into four groups: DN, control, DN treated with exosomes and sham. First, diabetes was induced in the rats by intraperitoneial (i.p.) administration of streptozotocin (STZ, 50 mg/kg body weight). Then, the exosomes were injected each week into their tail vein for six weeks. We measured 24-hour urine protein, blood urea nitrogen (BUN), and serum creatinine (Scr) levels with detection kits. The histopathological effects of the exosomes on kidneys were evaluated by periodic acid-Schiff (PAS) staining and expressions of miRNA-29a and miRNA-377 by quantitative real-time polymerase chain reaction (qRT-PCR). Results The KTC-Exos were approximately 50-150 nm and had a spherical morphology. They expressed the CD9 and CD63 specific markers. Intravenous injections of KTC-Exos potentially reduced urine volume (P<0.0001), and 24- hour protein (P<0.01), BUN (P<0.001) and Scr (P<0.0001) levels. There was a decrease in miRNA-377 (P<0.01) and increase in miRNA-29a (P<0.001) in the diabetic rats. KTC-Exos ameliorated the renal histopathology with regulatory changes in microRNAs (miRNA) expressions. Conclusion KTC-Exos plays a role in attenuation of kidney injury from diabetes by regulating the miRNAs associated with DN.

[1]  S. Nazifi,et al.  Cyclohexane extract of walnut leaves improves indices of oxidative stress, total homocysteine and lipids profiles in streptozotocin‐induced diabetic rats , 2020, Physiological reports.

[2]  Ling Li,et al.  Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source , 2020, Drug delivery.

[3]  N. Moradi,et al.  Captopril and Spironolactone Can Attenuate Diabetic Nephropathy in Wistar Rats by Targeting microRNA-192 and microRNA-29a/b/c. , 2019, DNA and cell biology.

[4]  G. Cai,et al.  miRNAs in stem cell-derived extracellular vesicles for acute kidney injury treatment: comprehensive review of preclinical studies , 2019, Stem Cell Research & Therapy.

[5]  M. Chen,et al.  Complement deposition on renal histopathology of patients with diabetic nephropathy. , 2019, Diabetes & metabolism.

[6]  C. Pollock,et al.  MicroRNA as novel biomarkers and therapeutic targets in diabetic kidney disease: An update , 2019, FASEB bioAdvances.

[7]  X. Niu,et al.  Exosomes secreted by urine-derived stem cells improve stress urinary incontinence by promoting repair of pubococcygeus muscle injury in rats , 2019, Stem cell research & therapy.

[8]  Hailing Yang,et al.  Key Genes and Signaling Pathways Contribute to the Pathogensis of Diabetic Nephropathy. , 2019, Iranian journal of kidney diseases.

[9]  T. Thum,et al.  Circulating miRNAs as mediators in cell-to-cell communication. , 2019, Epigenomics.

[10]  Chun-Wu Tung,et al.  MicroRNA-29a Attenuates Diabetic Glomerular Injury through Modulating Cannabinoid Receptor 1 Signaling , 2019, Molecules.

[11]  X. Zhan,et al.  Celastrol antagonizes high glucose‐evoked podocyte injury, inflammation and insulin resistance by restoring the HO‐1‐mediated autophagy pathway , 2018, Molecular immunology.

[12]  D. Sabry,et al.  Mesenchymal Stem Cell-Derived Exosomes Ameliorated Diabetic Nephropathy by Autophagy Induction through the mTOR Signaling Pathway , 2018, Cells.

[13]  J. Chan,et al.  MicroRNA and Diabetic Complications: A Clinical Perspective. , 2018, Antioxidants & redox signaling.

[14]  Mitsuo Kato.  Noncoding RNAs as therapeutic targets in early stage diabetic kidney disease , 2018, Kidney research and clinical practice.

[15]  G. Al-Kafaji,et al.  Expression of microRNA‑377 and microRNA‑192 and their potential as blood‑based biomarkers for early detection of type 2 diabetic nephropathy. , 2018, Molecular medicine reports.

[16]  Qin Huang,et al.  Glucagon‑like peptide‑1 protects mouse podocytes against high glucose‑induced apoptosis, and suppresses reactive oxygen species production and proinflammatory cytokine secretion, through sirtuin 1 activation in vitro. , 2018, Molecular medicine reports.

[17]  M. Ghahremani,et al.  Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine , 2018, Stem Cell Research & Therapy.

[18]  F. Hochberg,et al.  Extracellular vesicles: the growth as diagnostics and therapeutics; a survey , 2018, Journal of extracellular vesicles.

[19]  L. Gnudi,et al.  Diabetic nephropathy: Is there a role for oxidative stress? , 2018, Free radical biology & medicine.

[20]  J. Dominguez,et al.  Renal Tubular Cell-Derived Extracellular Vesicles Accelerate the Recovery of Established Renal Ischemia Reperfusion Injury. , 2017, Journal of the American Society of Nephrology : JASN.

[21]  G. Capasso,et al.  MicroRNAs in Renal Diseases: A Potential Novel Therapeutic Target , 2017, Kidney Diseases.

[22]  Mi-kyung Kim.  Treatment of diabetic kidney disease: current and future targets , 2017, The Korean journal of internal medicine.

[23]  Yongmin Yan,et al.  Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Relieve Inflammatory Bowel Disease in Mice , 2017, BioMed research international.

[24]  Douglas E Schaubel,et al.  US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  L. Lerman,et al.  Mesenchymal Stem Cell-derived Extracellular Vesicles for Renal Repair. , 2017, Current gene therapy.

[26]  M. Fujimiya,et al.  Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes , 2016, Scientific Reports.

[27]  D. Fraser,et al.  MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy , 2016, Current Diabetes Reports.

[28]  X. Niu,et al.  Exosomes secreted by human urine-derived stem cells could prevent kidney complications from type I diabetes in rats , 2016, Stem Cell Research & Therapy.

[29]  J. Ahmad.  Management of diabetic nephropathy: Recent progress and future perspective. , 2015, Diabetes & metabolic syndrome.

[30]  V. Gattone,et al.  Improved Structure and Function in Autosomal Recessive Polycystic Rat Kidneys with Renal Tubular Cell Therapy , 2015, PloS one.

[31]  J. Górriz,et al.  The Concept and the Epidemiology of Diabetic Nephropathy Have Changed in Recent Years , 2015, Journal of clinical medicine.

[32]  Xu Gao,et al.  The balance mediated by miRNAs and the heme oxygenase 1 feedback loop contributes to biological effects , 2013, Journal of cellular biochemistry.

[33]  Merlin C. Thomas,et al.  Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis. , 2012, Journal of the American Society of Nephrology : JASN.

[34]  Qingjuan Liu,et al.  Attenuation of Glomerular Injury in Diabetic Mice with Tert-Butylhydroquinone through Nuclear Factor Erythroid 2-Related Factor 2-Dependent Antioxidant Gene Activation , 2011, American Journal of Nephrology.

[35]  Hui Zhou,et al.  High glucose down‐regulates miR‐29a to increase collagen IV production in HK‐2 cells , 2010, FEBS letters.

[36]  J. Klein,et al.  Exogenous miR-29a Attenuates Muscle Atrophy and Kidney Fibrosis in Unilateral Ureteral Obstruction Mice , 2020 .

[37]  Jian-Si Li,et al.  Renal Injury Repair: How About the Role of Stem Cells. , 2019, Advances in experimental medicine and biology.

[38]  Seyed Mahmoud Hashemi,et al.  Isolation and characterization of exosomes separated from stem cells by ultra-centrifuge method , 2018 .